Fridays review: pricing, fine print, and how it ranks

The price, in words

On tirzepatide, Fridays prices out at $359 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $240/mo (annual plan). That ranks #13 of 17 priced compounded programs — $144 a month above the field's floor (NexLife at $215). Semaglutide runs $175 a month all-in. (#5 of 19 on our semaglutide basis)

What the fine print says

The $240/mo figure requires paying the annual plan up front; in a contested regulatory environment, read the refund terms before locking a year into any compounded program. Recorded from third-party round-ups; we could not capture a figure on Fridays' own pricing page at the capture date.

Pharmacy & transparency

Price evidence: Third-party-reported, last verified 2026-08-05. The dispensing pharmacy is not named publicly — the single most common transparency gap in this market. Ask which pharmacy fills the prescription, whether it is 503A or 503B, and whether a certificate of analysis is available; our pharmacy guide explains what each answer means.

The dose ladder, priced rung by rung

Fridays prices the ladder as a flat line — $359 whether the syringe draws 2.5 mg in week one or 15 mg in year two. The practical consequences compound over a treatment course: the standard four-month climb to 10 mg costs exactly $1,436 (four flat months, no arithmetic), a post-plateau escalation from 10 to 12.5 mg is clinically free, and holding a dose an extra month for tolerability — the standard side-effect play — changes nothing on the bill. Against dose-scaled competitors whose entry figures climb 40–75% by maintenance, and against Zepbound's $299→$449 steps, a flat ladder means the advertised number is the number you keep paying.

What the first year actually bills

Run the calendar and Fridays's year one totals $4,308 at the standing rate: twelve identical charges of $359, titration included, because the flat structure makes month one and month twelve the same line item. Prepay and the effective rate drops to $240/month (annual plan), an annualized $2,880 — a real $1,428 saving against the standing year, purchased with locked funds whose refund terms deserve a read in a contested regulatory year. Benchmarked to the verified floor, the year costs $1,728 more than NexLife's $2,580 — the premium a buyer should be able to name a reason for. Brand context: Zepbound's comparable first year via LillyDirect runs about $5,188 on a standard titration, and $5,388 for a full year already at maintenance.

The 24-month view

On a two-year view, the standing plan totals $8,616 at Fridays, against $5,760 if the prepaid rate could be held for both years ($2,856 of committed-money savings). The same 24 months cost $5,160 at the verified floor and $10,776 on brand Zepbound at maintenance — bookends worth writing on the first invoice.

The semaglutide side of the house

On the cheaper molecule, Fridays bills $175/month all-in, ranking #5 of 19 on our verified semaglutide basis — against a field floor of $133 (Oak Longevity, with state limits) and brand Wegovy's flat $349. The in-house premium for stepping up to tirzepatide is $184/month — the local price of SURMOUNT-5's 20.2%-vs-13.7% head-to-head result, and a switch that stays inside one program's intake and pharmacy relationships.

Where it sits in the market

On the verified tirzepatide board, Fridays's $359 all-in rate ranks #13 of 17: $144/month above the NexLife floor; one rung cheaper sits Lavender Sky Health at $352 (a $7/mo gap); one rung pricier is MEDVi at $399. Against the FDA-approved benchmark, the same year costs $1,080 less than Zepbound's $449 maintenance tier — the discount a buyer is accepting compounded-product risk to collect. The full board, sortable and dated, is the tirzepatide ranking.

Three buyers, priced honestly

The week-one starter. First month at the 2.5 mg rung: $359 — same as every later month on the flat plan. The 10 mg maintainer. Settled at maintenance, the run-rate is $359/month, $4,308/year — the figure that should anchor any comparison, since it describes years two and three, not the promo. The prepay optimizer. Committing to the annual plan cuts the effective rate to $240/month ($2,880/yr) — cheapest path here, least flexible money, refund terms first.

Nearest alternatives at this price point

Shopping the immediate neighborhood, the closest verified substitutes are Lavender Sky Health at $352 (source-verified); Henry Meds at $349 (flat at every dose, no membership, prepaid to $297); TrimRx at $349 (flat at every dose, no membership, prepaid to $293) — each linked matchup runs the full head-to-head arithmetic on this exact question.

State availability

Fridays publishes availability of: not published. State-by-state context, exceptions, and city coverage live in the 51-state cost guides.

Five questions before checkout

Whatever the marketing says, get answers to: (1) the all-in monthly price at 10 mg and at 12.5 mg, in writing, including every mandatory fee; (2) which pharmacy, by name, fills the prescription — and whether it's 503A or 503B, licensed for your state, with a certificate of analysis available; (3) the refund terms on the prepaid plan, verbatim, before any multi-month charge; (4) the cancellation mechanics — deadline relative to renewal, written-confirmation availability, and whether any membership cancels separately. A program that answers all five plainly has already told you most of what this review can.

Visit Fridays — verify current pricing →Opens the provider’s own pricing page; our figures were captured 2026-08-05.

Bottom line

Fridays is one of the more expensive tirzepatide programs we track. For context, the verified market floor is $215/mo compounded tirzepatide and $133/mo compounded semaglutide, with brand Zepbound at $449/mo and Wegovy at $349/mo at maintenance.